DR

Dileep Ramrao Fugare

Director Director DIN 01969613
DIN 01969613 First appointment Jan 2004 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Dileep Ramrao Fugare

Data last updated:

Dileep Ramrao Fugare was a Director at Shri Gurunanak Hospitals And Research Ce Nter Limited (2004–2008) and Director at Apeksha Superspeciality Hospital And Critical Care Center Private Limited (2014). The companies operate in Healthcare.

DIN 01969613
Primary Designation Director
Industry Healthcare
First Appointment 23 Jan 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jan 20042004Strike Off
Director15 Mar 20142014₹24.3 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Shri Gurunanak Hospitals And Research Ce Nter Limited
Apeksha Superspeciality Hospital And Critical Care Center Private Limited
Premium access

Shareholding and investment profile for Dileep Ramrao Fugare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dileep Ramrao Fugare

Dileep Ramrao Fugare was first appointed on 23 Jan 2004 as Director at Shri Gurunanak Hospitals And Research Ce Nter Limited. The most recent appointment on record is 15 Mar 2014 at Apeksha Superspeciality Hospital And Critical Care Center Private Limited.

Dileep Ramrao Fugare held 2 earlier board appointments: Shri Gurunanak Hospitals And Research Ce Nter Limited (Director, 23 Jan 2004 to 27 Sep 2008); Apeksha Superspeciality Hospital And Critical Care Center Private Limited (Director, 15 Mar 2014 to 31 Mar 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available